Loading clinical trials...
Loading clinical trials...
Radiation Induced Toxicity in Prostate Cancer
The goal is to gain insight in the development and course of the toxicity after a curative treatment of prostate cancer
All with curative intent treated prostate cancer patients will be enrolled in the SFP (Standard Follow-up Programme). It also includes the post -operative adjuvant treatments and the patients with positive lymph nodes. Patients will complete weekly questionnaires to score the patient -rated toxicity. Biweekly patients are seen by the treating radiation oncologist and / or AIOS in which the physician -rated toxicity is scored. In the follow-up will always patient -rated toxicity and physician -rated toxicity can be determined. Use of an SFP should yield a profit for the practitioner , such as the automatic generation of letters. This should apply to all SFPs . Quality of life and toxicity in patients will be completed on the touch-screen computers at FU visits.
Age
18 - No limit years
Sex
MALE
Healthy Volunteers
No
University Medical Center Groningen
Groningen, Netherlands
Start Date
April 1, 1999
Primary Completion Date
January 1, 2025
Completion Date
January 1, 2028
Last Updated
October 18, 2023
10,000
ESTIMATED participants
Lead Sponsor
University Medical Center Groningen
NCT04550494
NCT06842498
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05691465